agilon health, inc.
US ˙ NYSE

SecurityAGL / agilon health, inc.
InsiderJohn William Wulf
This page shows the track record and history of Wulf John William insider trades in agilon health, inc.. The SEC defines Insiders as officers, directors, or significant investors (greater than 10% ownership) in a company. It is illegal for insiders to make trades in their companies based on material, non-public information ("MNPI"). This does not mean it is illegal for them to make any trades in their own companies. However, they must report all trades to the SEC via a Form 4.
Insider Purchases - Short Term Profit Analysis

In this section, we analyze the profitability of every unplanned, open-market insider purchase made by John William Wulf in AGL / agilon health, inc.. This analysis helps to understand if the insider consistently generates abnormal returns, and is worth following. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market purchases that were not part of an automatic trading plan.

Trade Date Reported
Shares		 Reported
Price		 Adjusted
Shares		 Adjusted
Price		 Cost Basis Days to
Max		 Price at
Max		 Max
Profit ($)		 Max Return (%)
2025-11-12 81,000 0.6289 3,240 15.7225 50,941 205 96.8500 262,854 516.01
2024-12-05 45,000 2.1810 1,800 54.5250 98,145

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

AGL / agilon health, inc. Insider Trades
Insider Sales - Short Term Loss Analysis

In this section, we analyze the short-term loss avoidance of every unplanned, open-market insider sale made by John William Wulf in AGL / agilon health, inc.. A consistent pattern of loss avoidance may suggest that future sale transactions may predict declines in price. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market purchases that were not part of an automatic trading plan.

Trade Date Reported
Shares		 Reported
Price		 Adjusted
Shares		 Adjusted
Price		 Cost Basis Days to
Min		 Price at
Min		 Max Loss
Avoided ($)		 Max Loss
Avoided (%)
2023-03-15 80,000 23.8153 3,200 595.3825 1,905,224 365 5.2300 -1,888,488 -99.12
2022-03-15 11,100 19.1300 444 478.2500 212,343
2022-03-15 19,708 19.0800 788 477.0000 376,029
2021-09-14 15,342 28.9800 614 724.5000 444,611

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

AGL / agilon health, inc. Insider Trades
Insider Transaction History
File
Date		 Trade
Date		 Form Insider Ticker Security Title Code 10b5-1 Direct Exercise
Price		 Unit
Price		 Units
Changed		 Value
Changed (1K)		 Remaining
Options		 Remaining
Shares
2026-06-04 2026-06-02 4 Wulf John William AGL Common Stock A - Award D 2,133 16,765
2026-01-30 2025-11-12 4 Wulf John William AGL Common Stock P - Purchase D 0.6289 81,000 51 365,857
2025-05-30 2025-05-28 4 Wulf John William AGL Common Stock A - Award D 78,724 284,857
2024-12-11 2024-12-05 4 Wulf John William AGL Common Stock P - Purchase D 2.1810 45,000 98 206,133
2024-05-31 2024-05-29 4 Wulf John William AGL Common Stock A - Award D 32,119 161,133
2023-04-18 2023-04-14 4 Wulf John William AGL Common Stock A - Award D 5,622 129,014
2023-03-17 2023-03-15 4 Wulf John William AGL Common Stock S - Sale D 23.8153 -80,000 -1,905 123,392
2023-03-17 2023-03-15 4 Wulf John William AGL Common Stock M - Exercise D 4.5000 80,000 360 203,392
2022-04-20 2022-04-14 4 Wulf John William AGL Common Stock A - Award D 6,936 123,392
2022-03-16 2022-03-15 4 Wulf John William AGL Common Stock S - Sale D 19.0800 -19,708 -376 116,456
2022-03-16 2022-03-15 4 Wulf John William AGL Common Stock S - Sale D 19.1300 -11,100 -212 136,164
2021-09-15 2021-09-14 4 Wulf John William AGL Common Stock S - Sale D 28.9800 -15,342 -445 147,264
2021-04-16 2021-04-14 4 Wulf John William AGL Common Stock A - Award D 6,956 127,556
2021-04-14 3 Wulf John William AGL Common Stock D 120,600
P
Acquisto sul mercato aperto o privato di un titolo non derivato o derivato
S
Vendita sul mercato aperto o privato di un titolo non derivato o derivato
A
Concessione, assegnazione o altra acquisizione di titoli dall'azienda (ad esempio un'opzione)
C
Conversione di un derivato
D
Vendita o trasferimento di titoli alla società
F
Pagamento del prezzo di esercizio o del debito fiscale con la quota di titoli ricevuta dalla società
G
Regalo di titoli da parte o a favore dell'insider
K
Equity swap e operazioni di copertura analoghe
M
Esercizio o conversione di un titolo derivato ricevuto dall'azienda (ad esempio un'opzione)
V
Una transazione dichiarata volontariamente sul modulo 4
J
Altro (accompagnato da una nota a piè di pagina che descriva l'operazione)